Emerging markets might not be all they’re cracked up to be for healthcare companies, according to a Frost & Sullivan report, as protectionist import policies and competition from generics prove to be big challenges.
Markets the so-called BRIC countries – Brazil, Russia, India and China – aren’t proving to be as easy to penetrate as healthcare companies once thought, according to F&S partner Reenita Das.